GlassScriptPhysician profile
Kenneth M Sekine
NPI 1841299625
$1,419.47
in general payments reported to CMS, 2019-2025
27 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $143 · 2021: $156 · 2022: $407 · 2023: $212 · 2024: $101 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $159.60 | 2019-2025 | |
| Hologic Sales and Service, LLC | $133.51 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $119.35 | 2021-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $113.47 | 2019-2024 | |
| Novo Nordisk INC | $110.28 | 2019 | |
| Therapeuticsmd, INC. | $79.26 | 2020-2022 | |
| Coloplast Corp | $71.25 | 2022-2023 | Saffron |
| Millicent US INC | $64.90 | 2019-2025 | Intrarosa |
| Shield Therapeutics INC | $53.77 | 2022 | |
| Evofem Biosciences, INC. | $53.46 | 2020-2022 | |
| Organon LLC | $52.84 | 2021-2025 | Jada System |
| Lilly USA, LLC | $52.36 | 2024-2025 | Zepbound |
| Covidien LP | $49.04 | 2019-2020 | |
| Minerva Surgical, INC | $38.28 | 2019-2023 | |
| Coopersurgical, INC. | $37.78 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $37.66 | 2021-2022 | |
| Radius Health, INC. | $31.22 | 2022 | |
| Lupin INC. | $26.16 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.79 | 2019 | |
| Exact Sciences Corporation | $21.60 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $20.57 | 2023 | Myfembree |
| Exeltis, USA INC. | $16.38 | 2021 | |
| Endo Pharmaceuticals INC. | $15.10 | 2022 | |
| Avion Pharmaceuticals | $13.59 | 2020 | |
| Scynexis, INC. | $12.82 | 2022 | |
| Amgen INC. | $12.43 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Sekine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.